Agents from three novel drug classes showed safety and hints of efficacy in patients with varying stages of chronic kidney disease in three phase 2 studies at the European Renal Association Congress.
Contrary to current conventional wisdom, patients with chronic kidney disease who develop mild or moderate acute kidney injury have only a small subsequent worsening of kidney function.
Doctors and researchers have been trying to end the obesity epidemic for decades and have failed. Can a new set of effective drugs finally succeed? Second in a 3-part series on the obesity crisis.
MyJournals.org - Science - IJMS, Vol. 24, Pages 10829: A2BAR Antagonism Decreases the Glomerular Expression and Secretion of Chemoattractants for Monocytes and the Pro-Fibrotic M2 Macrophages Polarization during Diabetic Nephropathy (International Journal of Molecular Sciences)
Brussels must act to prevent essential medical devices for children from disappearing in the European Union in the next year, the European Academy of Paediatrics warned on Tuesday.